{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:49:03Z","timestamp":1787698143569,"version":"build-2784847793"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,7,6]],"date-time":"2018-07-06T00:00:00Z","timestamp":1530835200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuromol Med"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s12017-018-8499-5","type":"journal-article","created":{"date-parts":[[2018,7,6]],"date-time":"2018-07-06T02:18:42Z","timestamp":1530843522000},"page":"376-385","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Cerebrospinal Fluid C-Reactive Protein in Parkinson\u2019s Disease: Associations with Motor and Non-motor Symptoms"],"prefix":"10.1007","volume":"20","author":[{"given":"Hossein","family":"Sanjari Moghaddam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Valitabar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Ashraf-Ganjouei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahtab","family":"Mojtahed Zadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzaneh","family":"Ghazi Sherbaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5550-9782","authenticated-orcid":false,"given":"Mohammad Hadi","family":"Aarabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,6]]},"reference":[{"issue":"4","key":"8499_CR1","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s11910-012-0283-6","volume":"12","author":"CJ Barnum","year":"2012","unstructured":"Barnum, C. J., & Tansey, M. G. (2012). Neuroinflammation and non-motor symptoms: The dark passenger of Parkinson\u2019s disease? Current Neurology and Neuroscience Reports, 12(4), 350\u2013358. \n                    https:\/\/doi.org\/10.1007\/s11910-012-0283-6\n                    \n                  .","journal-title":"Current Neurology and Neuroscience Reports"},{"key":"8499_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2008.03975.x","author":"I Berczi","year":"2009","unstructured":"Berczi, I., Quintanar-Stephano, A., & Kovacs, K. (2009) Neuroimmune regulation in immunocompetence, acute illness, and healing. Annals of the New York Academy of Sciences. \n                    https:\/\/doi.org\/10.1111\/j.1749-6632.2008.03975.x\n                    \n                  .","journal-title":"Annals of the New York Academy of Sciences"},{"key":"8499_CR3","doi-asserted-by":"publisher","first-page":"967839","DOI":"10.4061\/2011\/967839","volume":"2011","author":"YM Bordelon","year":"2011","unstructured":"Bordelon, Y. M., Hays, R. D., Vassar, S. D., Diaz, N., Bronstein, J., & Vickrey, B. G. (2011). Medication responsiveness of motor symptoms in a population-based study of Parkinson disease. Parkinson\u2019s Disease, 2011, 967839. \n                    https:\/\/doi.org\/10.4061\/2011\/967839\n                    \n                  .","journal-title":"Parkinson\u2019s Disease"},{"issue":"1","key":"8499_CR4","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1093\/aje\/kwm260","volume":"167","author":"H Chen","year":"2008","unstructured":"Chen, H., O\u2019Reilly, E. J., Schwarzschild, M. A., & Ascherio, A. (2008). Peripheral inflammatory biomarkers and risk of Parkinson\u2019s disease. American Journal of Epidemiology, 167(1), 90\u201395. \n                    https:\/\/doi.org\/10.1093\/aje\/kwm260\n                    \n                  .","journal-title":"American Journal of Epidemiology"},{"issue":"2","key":"8499_CR5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.cyto.2010.02.011","volume":"50","author":"D Closhen","year":"2010","unstructured":"Closhen, D., Bender, B., Luhmann, H. J., & Kuhlmann, C. R. (2010). CSF CRP-induced levels of oxidative stress are higher in brain than aortic endothelial cells. Cytokine, 50(2), 117\u2013120. \n                    https:\/\/doi.org\/10.1016\/j.cyto.2010.02.011\n                    \n                  .","journal-title":"Cytokine"},{"issue":"1","key":"8499_CR6","doi-asserted-by":"publisher","first-page":"e55375","DOI":"10.1371\/journal.pone.0055375","volume":"8","author":"G Codolo","year":"2013","unstructured":"Codolo, G., Plotegher, N., Pozzobon, T., Brucale, M., Tessari, I., Bubacco, L., & de Bernard, M. (2013). Triggering of inflammasome by aggregated alpha-synuclein, an inflammatory response in synucleinopathies. PLoS ONE, 8(1), e55375. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0055375\n                    \n                  .","journal-title":"PLoS ONE"},{"issue":"1","key":"8499_CR7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nrn2297","volume":"9","author":"R Dantzer","year":"2008","unstructured":"Dantzer, R., O\u2019Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008). From inflammation to sickness and depression: When the immune system subjugates the brain. Nature Reviews Neuroscience, 9(1), 46\u201356. \n                    https:\/\/doi.org\/10.1038\/nrn2297\n                    \n                  .","journal-title":"Nature Reviews Neuroscience"},{"issue":"3","key":"8499_CR8","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3727\/000000007783464731","volume":"16","author":"BS Desai","year":"2007","unstructured":"Desai, B. S., Monahan, A. J., Carvey, P. M., & Hendey, B. (2007). Blood-brain barrier pathology in Alzheimer\u2019s and Parkinson\u2019s disease: Implications for drug therapy. Cell Transplantation, 16(3), 285\u2013299.","journal-title":"Cell Transplantation"},{"issue":"7","key":"8499_CR9","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1212\/WNL.0b013e318264e3be","volume":"79","author":"M Napoli Di","year":"2012","unstructured":"Di Napoli, M., Godoy, D. A., Campi, V., Masotti, L., Smith, C. J., Jones, A. R. P., et al. (2012). C-reactive protein in intracerebral hemorrhage: Time course, tissue localization, and prognosis. Neurology, 79(7), 690\u2013699. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e318264e3be\n                    \n                  .","journal-title":"Neurology"},{"issue":"1\u20132","key":"8499_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cnr.2006.04.002","volume":"6","author":"AJ Dunn","year":"2006","unstructured":"Dunn, A. J. (2006). Effects of cytokines and infections on brain neurochemistry. Clinical Neuroscience Research, 6(1\u20132), 52\u201368. \n                    https:\/\/doi.org\/10.1016\/j.cnr.2006.04.002\n                    \n                  .","journal-title":"Clinical Neuroscience Research"},{"issue":"1","key":"8499_CR11","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/S0006-8993(96)01359-5","volume":"749","author":"T Duong","year":"1997","unstructured":"Duong, T., Nikolaeva, M., & Acton, P. J. (1997). C-reactive protein-like immunoreactivity in the neurofibrillary tangles of Alzheimer\u2019s disease. Brain Research, 749(1), 152\u2013156.","journal-title":"Brain Research"},{"key":"8499_CR12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jneuroim.2015.04.014","volume":"283","author":"E Dursun","year":"2015","unstructured":"Dursun, E., Gezen-Ak, D., Hanagasi, H., Bilgic, B., Lohmann, E., Ertan, S., et al. (2015). The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer\u2019s disease, mild cognitive impairment or Parkinson\u2019s disease. Journal of Neuroimmunology, 283, 50\u201357. \n                    https:\/\/doi.org\/10.1016\/j.jneuroim.2015.04.014\n                    \n                  .","journal-title":"Journal of Neuroimmunology"},{"key":"8499_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2017.10.050","author":"M Haghshomar","year":"2017","unstructured":"Haghshomar, M., Rahmani, F., Hadi Aarabi, M., Shahjouei, S., Sobhani, S., & Rahmani, M. (2017). White matter changes correlates of peripheral neuroinflammation in patients with Parkinson's disease. Neuroscience. \n                    https:\/\/doi.org\/10.1016\/j.neuroscience.2017.10.050\n                    \n                  .","journal-title":"Neuroscience"},{"issue":"11","key":"8499_CR13","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/nn1997","volume":"10","author":"UK Hanisch","year":"2007","unstructured":"Hanisch, U. K., & Kettenmann, H. (2007). Microglia: Active sensor and versatile effector cells in the normal and pathologic brain. Nature Neuroscience, 10(11), 1387\u20131394. \n                    https:\/\/doi.org\/10.1038\/nn1997\n                    \n                  .","journal-title":"Nature Neuroscience"},{"issue":"4","key":"8499_CR14","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s00702-010-0535-z","volume":"118","author":"S Hassin-Baer","year":"2011","unstructured":"Hassin-Baer, S., Cohen, O. S., Vakil, E., Molshazki, N., Sela, B. A., Nitsan, Z., et al. (2011) Is C-reactive protein level a marker of advanced motor and neuropsychiatric complications in Parkinson\u2019s disease? Journal of Neural Transmission, 118(4), 539\u2013543. \n                    https:\/\/doi.org\/10.1007\/s00702-010-0535-z\n                    \n                  .","journal-title":"Journal of Neural Transmission"},{"key":"8499_CR15","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/j.1749-6632.2003.tb07478.x","volume":"991","author":"EC Hirsch","year":"2003","unstructured":"Hirsch, E. C., Breidert, T., Rousselet, E., Hunot, S., Hartmann, A., & Michel, P. P. (2003). The role of glial reaction and inflammation in Parkinson\u2019s disease. Annals of the New York Academy of Sciences, 991, 214\u2013228.","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"4","key":"8499_CR16","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","volume":"8","author":"EC Hirsch","year":"2009","unstructured":"Hirsch, E. C., & Hunot, S. (2009). Neuroinflammation in Parkinson\u2019s disease: A target for neuroprotection? The Lancet Neurology, 8(4), 382\u2013397. \n                    https:\/\/doi.org\/10.1016\/s1474-4422(09)70062-6\n                    \n                  .","journal-title":"The Lancet Neurology"},{"issue":"Suppl 1","key":"8499_CR17","doi-asserted-by":"publisher","first-page":"S210","DOI":"10.1016\/S1353-8020(11)70065-7","volume":"18","author":"EC Hirsch","year":"2012","unstructured":"Hirsch, E. C., Vyas, S., & Hunot, S. (2012). Neuroinflammation in Parkinson\u2019s disease. Parkinsonism & Related Disorders, 18(Suppl 1), S210\u2013S212. \n                    https:\/\/doi.org\/10.1016\/s1353-8020(11)70065-7\n                    \n                  .","journal-title":"Parkinsonism & Related Disorders"},{"issue":"1\u20132","key":"8499_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/0304-3940(94)90035-3","volume":"177","author":"N Iwamoto","year":"1994","unstructured":"Iwamoto, N., Nishiyama, E., Ohwada, J., & Arai, H. (1994). Demonstration of CSF CRP immunoreactivity in brains of Alzheimer\u2019s disease: Immunohistochemical study using formic acid pretreatment of tissue sections. Neuroscience Letters, 177(1\u20132), 23\u201326.","journal-title":"Neuroscience Letters"},{"issue":"6","key":"8499_CR19","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1002\/mds.26613","volume":"31","author":"UJ Kang","year":"2016","unstructured":"Kang, U. J., Goldman, J. G., Alcalay, R. N., Xie, T., Tuite, P., Henchcliffe, C., et al. (2016). The BioFIND study: Characteristics of a clinically typical Parkinson\u2019s disease biomarker cohort. Movement Disorders: Official Journal of the Movement Disorder Society, 31(6), 924\u2013932. \n                    https:\/\/doi.org\/10.1002\/mds.26613\n                    \n                  .","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"key":"8499_CR20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1742-2094-5-8","volume":"5","author":"JB Koprich","year":"2008","unstructured":"Koprich, J. B., Reske-Nielsen, C., Mithal, P., & Isacson, O. (2008). Neuroinflammation mediated by IL-1beta increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson\u2019s disease. Journal of Neuroinflammation, 5, 8. \n                    https:\/\/doi.org\/10.1186\/1742-2094-5-8\n                    \n                  .","journal-title":"Journal of Neuroinflammation"},{"issue":"16","key":"8499_CR21","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1002\/jnr.21810","volume":"86","author":"YN Li","year":"2008","unstructured":"Li, Y. N., Qin, X. J., Kuang, F., Wu, R., Duan, X. L., Ju, G., & Wang, B. R. (2008). Alterations of Fc gamma receptor I and Toll-like receptor 4 mediate the antiinflammatory actions of microglia and astrocytes after adrenaline-induced blood-brain barrier opening in rats. Journal of Neuroscience Research, 86(16), 3556\u20133565. \n                    https:\/\/doi.org\/10.1002\/jnr.21810\n                    \n                  .","journal-title":"Journal of Neuroscience Research"},{"key":"8499_CR22","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.bbi.2013.07.007","volume":"33","author":"D Lindqvist","year":"2013","unstructured":"Lindqvist, D., Hall, S., Surova, Y., Nielsen, H. M., Janelidze, S., Brundin, L., & Hansson, O. (2013). Cerebrospinal fluid inflammatory markers in Parkinson\u2019s disease: Associations with depression, fatigue, and cognitive impairment. Brain, Behavior, and Immunity, 33, 183\u2013189. \n                    https:\/\/doi.org\/10.1016\/j.bbi.2013.07.007\n                    \n                  .","journal-title":"Brain, Behavior, and Immunity"},{"issue":"10","key":"8499_CR23","doi-asserted-by":"publisher","first-page":"e47387","DOI":"10.1371\/journal.pone.0047387","volume":"7","author":"D Lindqvist","year":"2012","unstructured":"Lindqvist, D., Kaufman, E., Brundin, L., Hall, S., Surova, Y., & Hansson, O. (2012). Non-motor symptoms in patients with Parkinson\u2019s disease: Correlations with inflammatory cytokines in serum. PLoS ONE, 7(10), e47387. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0047387\n                    \n                  .","journal-title":"PLoS ONE"},{"issue":"5","key":"8499_CR24","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/nen.0b013e318053716a","volume":"66","author":"I Litvan","year":"2007","unstructured":"Litvan, I., Chesselet, M. F., Gasser, T., Di Monte, D. A., Parker, D. Jr., Hagg, T., et al. (2007). The etiopathogenesis of Parkinson disease and suggestions for future research. Part II. Journal of Neuropathology and Experimental Neurology, 66(5), 329\u2013336. \n                    https:\/\/doi.org\/10.1097\/nen.0b013e318053716a\n                    \n                  .","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"8499_CR25","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.neulet.2015.04.040","volume":"597","author":"Y Lv","year":"2015","unstructured":"Lv, Y., Zhang, Z., Hou, L., Zhang, L., Zhang, J., Wang, Y., et al. (2015). Phytic acid attenuates inflammatory responses and the levels of NF-kappaB and p-ERK in MPTP-induced Parkinson\u2019s disease model of mice. Neuroscience Letters, 597, 132\u2013136. \n                    https:\/\/doi.org\/10.1016\/j.neulet.2015.04.040\n                    \n                  .","journal-title":"Neuroscience Letters"},{"issue":"2","key":"8499_CR26","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0165-0173(95)00011-9","volume":"21","author":"PL McGeer","year":"1995","unstructured":"McGeer, P. L., & McGeer, E. G. (1995). The inflammatory response system of brain: Implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Research Reviews, 21(2), 195\u2013218. \n                    https:\/\/doi.org\/10.1016\/0165-0173(95)00011-9\n                    \n                  .","journal-title":"Brain Research Reviews"},{"issue":"Suppl 1","key":"8499_CR27","doi-asserted-by":"publisher","first-page":"S3-7","DOI":"10.1016\/j.parkreldis.2004.01.005","volume":"10","author":"PL McGeer","year":"2004","unstructured":"McGeer, P. L., & McGeer, E. G. (2004). Inflammation and neurodegeneration in Parkinson\u2019s disease. Parkinsonism & Related Disorders, 10(Suppl 1), S3-7. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2004.01.005\n                    \n                  .","journal-title":"Parkinsonism & Related Disorders"},{"issue":"6","key":"8499_CR28","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1176\/appi.psy.51.6.474","volume":"51","author":"M Menza","year":"2010","unstructured":"Menza, M., Dobkin, R. D., Marin, H., Mark, M. H., Gara, M., Bienfait, K., et al. (2010). The role of inflammatory cytokines in cognition and other non-motor symptoms of Parkinson\u2019s disease. Psychosomatics, 51(6), 474\u2013479. \n                    https:\/\/doi.org\/10.1176\/appi.psy.51.6.474\n                    \n                  .","journal-title":"Psychosomatics"},{"issue":"8","key":"8499_CR29","doi-asserted-by":"publisher","first-page":"999","DOI":"10.2174\/1381612053381620","volume":"11","author":"T Nagatsu","year":"2005","unstructured":"Nagatsu, T., & Sawada, M. (2005). Inflammatory process in Parkinson\u2019s disease: Role for cytokines. Current Pharmaceutical Design, 11(8), 999\u20131016.","journal-title":"Current Pharmaceutical Design"},{"issue":"5","key":"8499_CR30","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1161\/01.CIR.0000114526.50618.24","volume":"109","author":"A Paul","year":"2004","unstructured":"Paul, A., Ko, K. W., Li, L., Yechoor, V., McCrory, M. A., Szalai, A. J., & Chan, L. (2004). C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Circulation, 109(5), 647\u2013655. \n                    https:\/\/doi.org\/10.1161\/01.cir.0000114526.50618.24\n                    \n                  .","journal-title":"Circulation"},{"issue":"1\u20132","key":"8499_CR31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jneuroim.2010.02.018","volume":"222","author":"MC Pott Godoy","year":"2010","unstructured":"Pott Godoy, M. C., Ferrari, C. C., & Pitossi, F. J. (2010). Nigral neurodegeneration triggered by striatal AdIL-1 administration can be exacerbated by systemic IL-1 expression. Journal of Neuroimmunology, 222(1\u20132), 29\u201339. \n                    https:\/\/doi.org\/10.1016\/j.jneuroim.2010.02.018\n                    \n                  .","journal-title":"Journal of Neuroimmunology"},{"issue":"Pt 7","key":"8499_CR32","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1093\/brain\/awn101","volume":"131","author":"MC Pott Godoy","year":"2008","unstructured":"Pott Godoy, M. C., Tarelli, R., Ferrari, C. C., Sarchi, M. I., & Pitossi, F. J. (2008). Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson\u2019s disease. Brain: A Journal of Neurology, 131(Pt 7), 1880\u20131894. \n                    https:\/\/doi.org\/10.1093\/brain\/awn101\n                    \n                  .","journal-title":"Brain: A Journal of Neurology"},{"issue":"11","key":"8499_CR33","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1001\/jamaneurol.2016.2742","volume":"73","author":"XY Qin","year":"2016","unstructured":"Qin, X. Y., Zhang, S. P., Cao, C., Loh, Y. P., & Cheng, Y. (2016). Aberrations in peripheral inflammatory cytokine levels in Parkinson disease: A systematic review and meta-analysis. JAMA Neurology, 73(11), 1316\u20131324. \n                    https:\/\/doi.org\/10.1001\/jamaneurol.2016.2742\n                    \n                  .","journal-title":"JAMA Neurology"},{"key":"8499_CR34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1155\/2015\/628192","volume":"2015","author":"N Rocha","year":"2015","unstructured":"Rocha, N., Pessoa, l., de Miranda, A. S., & Teixeira, A. L. (2015). Insights into neuroinflammation in Parkinson\u2019s disease: From biomarkers to anti-inflammatory based therapies. BioMed Research International, 2015, 12. \n                    https:\/\/doi.org\/10.1155\/2015\/628192\n                    \n                  .","journal-title":"BioMed Research International"},{"issue":"4","key":"8499_CR47","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3389\/fneur.2018.00234","volume":"9","author":"H Sanjari Moghaddam","year":"2018","unstructured":"Sanjari Moghaddam, H., Ghazi Sherbaf, F., Mojtahed Zadeh, M., Ashraf-Ganjouei, A., & Aarabi, M. H. (2018). Association between peripheral inflammation and DATSCAN data of the striatal nuclei in different motor subtypes of Parkinson disease. Frontiers in Neurology, 9, 234. \n                    https:\/\/doi.org\/10.3389\/fneur.2018.00234\n                    \n                  .","journal-title":"Frontiers in Neurology"},{"issue":"1","key":"8499_CR35","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neulet.2009.10.062","volume":"468","author":"P Scalzo","year":"2010","unstructured":"Scalzo, P., Kummer, A., Cardoso, F., & Teixeira, A. L. (2010). Serum levels of interleukin-6 are elevated in patients with Parkinson\u2019s disease and correlate with physical performance. Neuroscience Letters, 468(1), 56\u201358. \n                    https:\/\/doi.org\/10.1016\/j.neulet.2009.10.062\n                    \n                  .","journal-title":"Neuroscience Letters"},{"issue":"2","key":"8499_CR36","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.pnpbp.2004.11.003","volume":"29","author":"OJG Schiepers","year":"2005","unstructured":"Schiepers, O. J. G., Wichers, M. C., & Maes, M. (2005). Cytokines and major depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 29(2), 201\u2013217. \n                    https:\/\/doi.org\/10.1016\/j.pnpbp.2004.11.003\n                    \n                  .","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"2","key":"8499_CR37","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/ana.10265","volume":"52","author":"R Schmidt","year":"2002","unstructured":"Schmidt, R., Schmidt, H., Curb, J. D., Masaki, K., White, L. R., & Launer, L. J. (2002). Early inflammation and dementia: A 25-year follow-up of the Honolulu-Asia Aging Study. Annals of Neurology, 52(2), 168\u2013174. \n                    https:\/\/doi.org\/10.1002\/ana.10265\n                    \n                  .","journal-title":"Annals of Neurology"},{"issue":"22","key":"8499_CR38","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1212\/01.wnl.0000263217.36439.da","volume":"68","author":"ZS Tan","year":"2007","unstructured":"Tan, Z. S., Beiser, A. S., Vasan, R. S., Roubenoff, R., Dinarello, C. A., Harris, T. B., et al. (2007). Inflammatory markers and the risk of Alzheimer disease: The Framingham Study. Neurology, 68(22), 1902\u20131908. \n                    https:\/\/doi.org\/10.1212\/01.wnl.0000263217.36439.da\n                    \n                  .","journal-title":"Neurology"},{"issue":"1","key":"8499_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.expneurol.2007.07.004","volume":"208","author":"MG Tansey","year":"2007","unstructured":"Tansey, M. G., McCoy, M. K., & Frank-Cannon, T. C. (2007). Neuroinflammatory mechanisms in Parkinson\u2019s disease: Potential environmental triggers, pathways, and targets for early therapeutic intervention. Experimental Neurology, 208(1), 1\u201325. \n                    https:\/\/doi.org\/10.1016\/j.expneurol.2007.07.004\n                    \n                  .","journal-title":"Experimental Neurology"},{"issue":"9","key":"8499_CR40","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1073\/pnas.0837397100","volume":"100","author":"P Teismann","year":"2003","unstructured":"Teismann, P., Tieu, K., Choi, D. K., Wu, D. C., Naini, A., Hunot, S., et al. (2003). Cyclooxygenase-2 is instrumental in Parkinson\u2019s disease neurodegeneration. Proceedings of the National Academy of Sciences of the United States of America, 100(9), 5473\u20135478. \n                    https:\/\/doi.org\/10.1073\/pnas.0837397100\n                    \n                  .","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"8499_CR41","doi-asserted-by":"publisher","first-page":"e94944","DOI":"10.1371\/journal.pone.0094944","volume":"9","author":"A Umemura","year":"2014","unstructured":"Umemura, A., Oeda, T., Tomita, S., Hayashi, R., Kohsaka, M., Park, K., et al. (2014). Delirium and high fever are associated with subacute motor deterioration in Parkinson disease: a nested case-control study. PLoS ONE, 9(6), e94944. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0094944\n                    \n                  .","journal-title":"PLoS ONE"},{"issue":"8","key":"8499_CR42","doi-asserted-by":"publisher","first-page":"e0136722","DOI":"10.1371\/journal.pone.0136722","volume":"10","author":"A Umemura","year":"2015","unstructured":"Umemura, A., Oeda, T., Yamamoto, K., Tomita, S., Kohsaka, M., Park, K., et al. (2015). Baseline plasma C-reactive protein concentrations and motor prognosis in Parkinson disease. PLoS ONE, 10(8), e0136722. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0136722\n                    \n                  .","journal-title":"PLoS ONE"},{"issue":"6","key":"8499_CR43","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1111\/j.1471-4159.2010.06879.x","volume":"114","author":"RF Villaran","year":"2010","unstructured":"Villaran, R. F., Espinosa-Oliva, A. M., Sarmiento, M., De Pablos, R. M., Arguelles, S., Delgado-Cortes, M. J., et al. (2010). Ulcerative colitis exacerbates lipopolysaccharide-induced damage to the nigral dopaminergic system: Potential risk factor in Parkinson`s disease. Journal of Neurochemistry, 114(6), 1687\u20131700. \n                    https:\/\/doi.org\/10.1111\/j.1471-4159.2010.06879.x\n                    \n                  .","journal-title":"Journal of Neurochemistry"},{"issue":"1","key":"8499_CR44","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S0006-8993(00)02970-X","volume":"887","author":"K Yasojima","year":"2000","unstructured":"Yasojima, K., Schwab, C., McGeer, E. G., & McGeer, P. L. (2000). Human neurons generate C-reactive protein and amyloid P: Upregulation in Alzheimer\u2019s disease. Brain Research, 887(1), 80\u201389. \n                    https:\/\/doi.org\/10.1016\/S0006-8993(00)02970-X\n                    \n                  .","journal-title":"Brain Research"},{"issue":"7","key":"8499_CR45","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1161\/01.RES.0000186188.38344.13","volume":"97","author":"ETH Yeh","year":"2005","unstructured":"Yeh, E. T. H. (2005). A new perspective on the biology of C-reactive protein. Circulation Research, 97(7), 609\u2013611. \n                    https:\/\/doi.org\/10.1161\/01.RES.0000186188.38344.13\n                    \n                  .","journal-title":"Circulation Research"},{"issue":"4","key":"8499_CR46","doi-asserted-by":"publisher","first-page":"e19333","DOI":"10.1371\/journal.pone.0019333","volume":"6","author":"L Zhang","year":"2011","unstructured":"Zhang, L., Yan, J., Xu, Y., Long, L., Zhu, C., Chen, X., et al. (2011). The combination of homocysteine and C-reactive protein predicts the outcomes of Chinese patients with Parkinson\u2019s disease and vascular parkinsonism. PLoS ONE, 6(4), e19333. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0019333\n                    \n                  .","journal-title":"PLoS ONE"}],"container-title":["NeuroMolecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12017-018-8499-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-018-8499-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-018-8499-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T19:16:01Z","timestamp":1562354161000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12017-018-8499-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,6]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["8499"],"URL":"https:\/\/doi.org\/10.1007\/s12017-018-8499-5","relation":{},"ISSN":["1535-1084","1559-1174"],"issn-type":[{"value":"1535-1084","type":"print"},{"value":"1559-1174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,6]]},"assertion":[{"value":"23 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}